Antenatal Corticosteroids and Childhood Infection Risk
Antenatal Steroids and Childhood Infections: A Growing Concern
Table of Contents
For decades, corticosteroids have been routinely administered to pregnant people at risk of preterm labor, between 24 and 34 weeks of gestation, to accelerate fetal lung development. This practice significantly reduces the risk of respiratory distress syndrome in newborns.However, emerging research suggests a potential link between these antenatal steroids and an increased risk of infection in children during their first few years of life.
What the New Research Reveals
A large, population-based study published in October 2023, and continuing to gain attention as of October 29, 2025, analyzed data from over 370,000 children born in Scotland. Researchers found that children exposed to antenatal corticosteroids had a modestly, but statistically significant, higher risk of being diagnosed with infection during childhood. Specifically, the risk increased by approximately 15%.
The study, which controlled for numerous confounding factors like socioeconomic status and maternal health conditions, indicated that the increased infection risk persisted through age five. While the absolute risk remains relatively low – meaning most children exposed to these steroids do not develop serious infections – the findings raise critically important questions about the long-term consequences of this widely used intervention.
Types of Infections and Severity
The increased risk wasn’t tied to any specific type of infection.Researchers observed a broad spectrum of infections, including respiratory infections, ear infections, and skin infections. Importantly, the study did not find a significant increase in the risk of severe infections requiring hospitalization, but further examination is warranted.
Why This Matters and What It Doesn’t Mean
this research does not suggest that pregnant people should forgo antenatal corticosteroids if they are at risk of preterm labor. The benefits of these medications in preventing respiratory distress syndrome remain ample, and this condition can be life-threatening for premature infants. However,it does highlight the need for a more nuanced understanding of the potential trade-offs involved.
“The key takeaway is not to panic, but to be informed,” explains Dr. Jennifer Chen, a leading expert in maternal-fetal medicine. “This study adds to a growing body of evidence suggesting that antenatal steroids may have subtle, long-term effects on the developing immune system. It’s crucial for healthcare providers to discuss these potential risks with expectant parents and to carefully weigh the benefits against the potential harms in each individual case.”
What’s Next?
Researchers are now focusing on identifying which babies are most vulnerable to the potential adverse effects of antenatal corticosteroids. Factors such as gestational age at the time of steroid administration, dosage, and individual genetic predispositions may all play a role. Further studies are also needed to determine whether modifying the timing or dosage of steroid administration could mitigate the risk of infection without compromising the benefits for lung development. Ongoing research aims to refine guidelines and ensure the safest possible care for both mothers and babies.
Parents with concerns should discuss these findings with their healthcare provider to make informed decisions about their care.
